JSKN016
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for JSKN016, covering 2024-09-19 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care [Phase 3]